Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation.

van Baar, Mireille L M; Guminski, Alex D; Ferguson, Peter M; Martin, Linda K

van Baar, Mireille L M; Guminski, Alex D; Ferguson, Peter M; Martin, Linda K.

Afiliação

van Baar MLM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Guminski AD; Radboud University Medical Center, Nijmegen, The Netherlands.
Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Martin LK; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.

JAAD Case Rep ; 5(6): 491-494, 2019 Jun.

Article em En | MEDLINE | ID: mdl-31193588

Palavras-chave

PD-1, programmed cell death 1; SCC, squamous cell carcinoma; cutaneous squamous cell carcinoma; granulomatous; immunotherapy; pembrolizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google